Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. Am. J. Life Sci. Innov. 2025, 4 (1), 27-35. https://doi.org/10.54536/ajlsi.v4i1.3268.